Low distribution of synaptic vesicle protein 2A and synaptotagimin-1 in the cerebral cortex and hippocampus of spontaneously epileptic rats exhibiting both tonic convulsion and absence seizure

[1]  K. Kurisu,et al.  Neuroprotective effect of levetiracetam on hippocampal sclerosis-like change in spontaneously epileptic rats , 2011, Brain Research Bulletin.

[2]  J. Reijneveld,et al.  Synaptic vesicle protein 2A predicts response to levetiracetam in patients with glioma , 2011, Neurology.

[3]  J. Gui,et al.  Children treated for epileptic encephalopathies show improved glucose metabolism , 2010, Pediatrics international : official journal of the Japan Pediatric Society.

[4]  Jean Gotman,et al.  Cortical and subcortical contributions to absence seizure onset examined with EEG/fMRI , 2010, Epilepsy & Behavior.

[5]  K. Kurisu,et al.  Hippocampal cell loss and propagation of abnormal discharges accompanied with the expression of tonic convulsion in the spontaneously epileptic rat , 2010, Brain Research.

[6]  Marco Salvatore,et al.  Thalamic activation and cortical deactivation during typical absence status monitored using [18F]FDG-PET: A case report , 2010, Seizure.

[7]  T. Serikawa,et al.  Preferential increase in the hippocampal synaptic vesicle protein 2A (SV2A) by pentylenetetrazole kindling. , 2009, Biochemical and biophysical research communications.

[8]  P. Ossenblok,et al.  Onset and propagation of spike and slow wave discharges in human absence epilepsy: A MEG study , 2009, Epilepsia.

[9]  Jie Yuan,et al.  Down-regulation Synaptic Vesicle Protein 2A in the Anterior Temporal Neocortex of Patients with Intractable Epilepsy , 2009, Journal of Molecular Neuroscience.

[10]  J. Reijneveld,et al.  Expression patterns of synaptic vesicle protein 2A in focal cortical dysplasia and TSC‐cortical tubers , 2009, Epilepsia.

[11]  E. Aronica,et al.  Decreased expression of synaptic vesicle protein 2A, the binding site for levetiracetam, during epileptogenesis and chronic epilepsy , 2009, Epilepsia.

[12]  J. Cross,et al.  Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology , 2009, Lancet Neurology.

[13]  T. Südhof,et al.  SV2 Renders Primed Synaptic Vesicles Competent for Ca2+-Induced Exocytosis , 2009, The Journal of Neuroscience.

[14]  Xue-feng Wang,et al.  Enhanced Synaptic Vesicle Traffic in Hippocampus of Phenytoin-Resistant Kindled Rats , 2009, Neurochemical Research.

[15]  W. van Paesschen,et al.  Neuronuclear assessment of patients with epilepsy. , 2008, Seminars in nuclear medicine.

[16]  J. Rizo,et al.  Synaptic vesicle fusion , 2008, Nature Structural &Molecular Biology.

[17]  K. Kurisu,et al.  Voltage‐dependent Calcium Channel Abnormalities in Hippocampal CA3 Neurons of Spontaneously Epileptic Rats , 2007, Epilepsia.

[18]  T. Vanaman,et al.  Asymmetric accumulation of hippocampal 7S SNARE complexes occurs regardless of kindling paradigm , 2007, Epilepsy Research.

[19]  M. Avoli,et al.  Synaptic hyperexcitability of deep layer neocortical cells in a genetic model of absence seizures , 2005, Genes, brain, and behavior.

[20]  C. Baumgartner,et al.  Aberrant expression of cytoskeleton proteins in hippocampus from patients with mesial temporal lobe epilepsy , 2006, Amino Acids.

[21]  Tadao Serikawa,et al.  Long‐lasting Antiepileptic Effects of Levetiracetam against Epileptic Seizures in the Spontaneously Epileptic Rat (SER): Differentiation of Levetiracetam from Conventional Antiepileptic Drugs , 2005, Epilepsia.

[22]  T. Serikawa,et al.  Separation of Antiepileptogenic and Antiseizure Effects of Levetiracetam in the Spontaneously Epileptic Rat (SER) , 2005, Epilepsia.

[23]  S. Mochida,et al.  SV2A and SV2C contain a unique synaptotagmin-binding site , 2005, Molecular and Cellular Neuroscience.

[24]  D. Johnston,et al.  Seizure-Induced Plasticity of h Channels in Entorhinal Cortical Layer III Pyramidal Neurons , 2004, Neuron.

[25]  M. Herkenham,et al.  Activin mRNA induced during amygdala kindling shows a spatiotemporal progression that tracks the spread of seizures , 2004, The Journal of comparative neurology.

[26]  Karl Herholz,et al.  Positron emission tomography in clinical neurology. , 2004, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.

[27]  K. Nocka,et al.  The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Xiling Wen,et al.  Reduced Inhibition and Increased Output of Layer II Neurons in the Medial Entorhinal Cortex in a Model of Temporal Lobe Epilepsy , 2003, The Journal of Neuroscience.

[29]  R. Racine,et al.  Activity-dependent changes in synaptophysin immunoreactivity in hippocampus, piriform cortex, and entorhinal cortex of the rat , 2002, Neuroscience.

[30]  Tao Xu,et al.  SV2 modulates the size of the readily releasable pool of secretory vesicles , 2001, Nature Cell Biology.

[31]  C. Özkara,et al.  GABA and l-glutamic acid release in en bloc resection slices of human hippocampus; an in vitro microdialysis study , 2001, Neurological Sciences.

[32]  Brian D. Hale,et al.  Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A). , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Markus Missler,et al.  SV2A and SV2B Function as Redundant Ca2+ Regulators in Neurotransmitter Release , 1999, Neuron.

[34]  K. Kurisu,et al.  Suppression by topiramate of epileptiform burst discharges in hippocampal CA3 neurons of spontaneously epileptic rat in vitro , 1998, Brain Research.

[35]  T. Serikawa,et al.  Inhibition by gamma-aminobutyric acid system activation of epileptic seizures in spontaneously epileptic rats. , 1998, Japanese journal of pharmacology.

[36]  W. Löscher,et al.  THE ROLE OF THE PIRIFORM CORTEX IN KINDLING , 1996, Progress in Neurobiology.

[37]  R. Scheller,et al.  Differential expression of synaptic vesicle protein 2 (SV2) isoforms , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[38]  T. Serikawa,et al.  Abnormal Excitability of Hippocampal CA3 Pyramidal Neurons of Spontaneously Epileptic Rats (SER), a Double Mutant , 1993, Experimental Neurology.

[39]  T. Serikawa,et al.  Local cerebral glucose utilization in the interictal state of the spontaneously epileptic rat (SER) , 1993, Brain Research.

[40]  J. Rothman,et al.  Intracellular membrane fusion. , 1991, Trends in biochemical sciences.

[41]  T. Serikawa,et al.  The spontaneously epileptic rat (SER), a zitter*tremor double mutant rat: histopathological findings in the central nervous system , 1990, Brain Research.

[42]  T. Serikawa,et al.  Effects of Antiepileptic Drugs on Absence‐Like and Tonic Seizures in the Spontaneously Epileptic Rat, a Double Mutant Rat , 1988, Epilepsia.

[43]  T. Serikawa,et al.  Epileptic seizures in rats homozygous for two mutations, zitter and tremor. , 1986, The Journal of heredity.

[44]  T. Serikawa,et al.  Rats with congenital tremor and curled whiskers and hair. , 1985, Jikken dobutsu. Experimental animals.

[45]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[46]  S. Rehm,et al.  A new rat mutant with defective overhairs and spongy degeneration of the central nervous system: clinical and pathologic studies. , 1982, Laboratory animal science.

[47]  J. Palacios,et al.  Increases and decreases in local cerebral glucose utilization in response to GABA agonists. , 1981, European journal of pharmacology.